濮陽惠成(300481.SZ):2020年淨利升23.66%至1.8億元 擬10派2元
格隆匯3月25日丨濮陽惠成(300481.SZ)披露2020年年度報吿,實現營業收入9.13億元,同比增長34.21%;歸屬於上市公司股東的淨利潤1.8億元,同比增長23.66%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.7億元,同比增長24.23%;基本每股收益0.70元,擬向全體股東每10股派發現金紅利2元(含税)。
公司作為國家高新技術企業,致力於順酐酸酐衍生物等精細化學品的研發、生產和銷售,為取得技術領先的市場地位,公司持續進行大力的研發投入,並取得了一定的研發成果。公司充分利用好國家級企業技術中心、省級有機小分子發光材料工程技術研究中心等研發平台,加強與河南省科學院化學研究所有限公司、鄭州輕工業大學、鄭州大學等科研院所、高校的產學研合作,繼續加大研發資金投入,加快新品開發步伐,培育新的利潤增長點。目前,公司已獲得授權專利87項(56項發明專利,31項實用新型專利)。先後獲得“國家火炬計劃重點高新技術企業”“國家知識產權優勢企業”“河南省創新龍頭企業”“國家綠色工廠”等稱號,曾獲得中國專利優秀獎、河南省科學技術進步一等獎、三等獎、河南省專利獎一等獎、河南省工業和信息化科技成果一等獎等獎項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.